Skip to main content

Elie Jabbour

Analyst

Professor, Department of Leukemia and Section Chief of Acute Lymphoblastic Leukemia, MD Anderson Cancer Center

Equibles does not estimate personal net worth.

About Elie Jabbour

Elie Jabbour is recorded as Analyst at Professor, Department of Leukemia and Section Chief of Acute Lymphoblastic Leukemia, MD Anderson Cancer Center. Elie Jabbour has spoken on 1 investor event across 1 company, most recently for Autolus Therapeutics plc on April 8, 2026. The companies whose calls Elie Jabbour spoke on are classified in the Healthcare sector.

Elie Jabbour on recent calls

“I'm so fortunate to be here today to be part of this journey where we will cure cancer, we cure ALL, and not only we cure ALL, but with sensitive and free use of aids.”
Analyst — Professor, Department of Leukemia and Section Chief of Acute Lymphoblastic Leukemia, MD Anderson Cancer Center, Virtual Investor Event: Spotlight on Acute Lymphoblastic Leukemia (ALL) Program ·

Affiliation history

  • Professor, Department of Leukemia and Section Chief of Acute Lymphoblastic Leukemia, MD Anderson Cancer Center

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity